Sinae APIs Categoria Factory

Active Pharmaceutical Ingredientia

Progestogen et Estrogen
Product Name	Specification	Probatus	CAS Non.
Progesterone	CP/EP/USP/JP	CEP/EU-GMP/FDA	57-83-0
Pregnenolone	In domo	Kosher	145-13-1
Medroxyprogesterone Acetate	CP/EP/USP/JP	DMF/GMP	71-58-9
Megestrol acetate	CP/EP/USP	DMF in processususus	595-33-5
Mifepristone	CP/IP	DMF/GMP	84371-65-3
Cyproterone Acetate	CP/EP/IP/KP	CEP/TGA/EU-GMP	427-51-0
Levonorgestrel	CP/EP/USP/IP	CEP/GMP	797-63-7
Norethisterone	CP/EP/USP/JP	DMF in processususus	68-22-4
Norethisterone Acetate	EP/USP	DMF in processususus	51-98-9
Norethisterone Enanthate	In domo	Sub R&D	3836-23-5
Drospirenone	EP/USP	DMF	67392-87-4
Gestodene	CP/EP	DMF/GMP	60282-87-3
Estradiol	CP/EP/USP/KP	DMF/GMP/WC	35380-71-3
Estriol	CP/EP/USP	Sub R&D	50-27- 1
Ethinyl Estradiol	CP/EP/USP	GMP	57-63-6
Estradiol Valerate	CP/EP/USP/KP	DMF	979-32-8
Estradiol Cypionatus	USP	DMF in processususus	313-06-4
Promestriene	In domo	Sub R&D	39219-28-8
Tibolone	CP/EP	DMF/GMP	5630-53-5
Dienogest	EP	CEP/GMP	65928-58-7
Fulvestrant	EP/USP	Sub R&D	129453-61-8
Exemestane	CP/EP/USP	Sub R&D	107868-30-4

Androgen
Product Name	Specification	Probatus	CAS Non.
Finasteride	CP/EP/USP	CEP/FDA/PMDA/GMP	98319-26-7
Dutasteride	EP/USP	CEP/FDA	164656-23-9
Abiraterone Acetate	CP/USP	DMF/GMP/WC	154229-18-2
Darolutamide	In domo	Sub R&D	1297538-32-9
Testosterone	CP/EP/USP	CEP/FDA/WC	58-22-0
Testosterone Undecanoate	CP	DMF/WC	5949-44-0
Testosterone Cypionate	USP	DMF	58-20-8
Testosterone Enanthate	USP/JP	Sub R&D	315-37-7
Testosterone Propionate	CP/EP/USP/JP	Sub R&D	57-85-2
DHEA	FP/In domo	DMF/WC/Kosher	53-43-0
Clascoterone	In domo	DMF in processususus	19608-29-8

Cortical Hormone
Product Name	Specification	Probatus	CAS Non.
Budesonide	CP/EP/USP/JP	CEP/FDA/GMP	51333-22-3
Desonide	CP/USP	DMF/GMP	638-94-8
Eplerenone	EP	CEP in processuu	107724-20-9
Methylprednisolone	CP/EP/USP/JP	DMF/GMP	83-43-2
Methylprednisolone Hemisuccinate	CP/EP/USP	DMF/GMP	2921-57-5
Fluticasone Propionate	CP/EP/USP	DMF	80474- 14-2
Fluticasone Furoate	CP/EP	DMF in processususus	397864-44-7
Mometasone Furoate	CP/EP/USP	DMF in processususus	Anhydrous (83919-23-7) Monohydratorum (141646-00-6)
Deflazacort	In domo	Sub R&D	14484-47-0

alii
Product Name	Specification	Probatus	CAS Non.
Oxcarbazepine	CP/EP/USP/IP	CEP/FDA/GMP	28721-07-5
Eslicarbazepine Acetate	CP/USP	DMF	236395- 14-5
Ganciclovir	CP/EP/USP	DMF/GMP	82410-32-0
Valganciclovir Hydrochloride	USP/EP	CEP in processu	175865-59-5
Oseltamivir Phosphate	CP/EP/USP	DMF	204255- 11-8
Baloxavir Marboxil	In domo	Sub R&D	1985606-14-1
Revefenacin	In domo	DMF	864750-70-9
Mirabegron	CP/EP	DMF	223673-61-8
Vibegron	In domo	Sub R&D	1190389-15-1
Escitalopram Oxalate	CP/EP/USP	DMF in processusus	219861-08-2
Citalopram Hydrobromide	CP/EP/USP	DMF in processususus	59729-32-7
Cariprazine hydrochloride	In domo	DMF	1083076-69-0
Lasmiditan Succinate	In domo	DMF	439239-92-6
Iuliconazole	In domo	DMF	187164-19-8
Nintedanib Esylate	In domo	FDA/DMF/WC	656247-18-6
Apalutami	In domo	DMF	956104-40-8
Tadalafil	CP/EP/USP	Sub R&D	171596-29-5
Relugolix	In domo	DMF in processusus	737789-87-6
Ruxolitinib phosphate	In domo	DMF in processususus	1092939-17-7
Abemaciclib	In domo	Sub R&D	1231929-97-7
Phloroglucinol	CP/EP	DMF	108-73-6
1,3,5-Trimethoxybenzene	CP/In-domus	GMP	621-23-8
Acidum Ursodeoxycholic	EP/USP/JP	Sub R&D	128-13-2
Tauroursodeoxycholic Acid	In domo	Sub R&D	14605-22-2
Cura	CP/EP/USP/JP	Sub R&D	57-88-5
Omega-3-Acid Ethyl Ethers 90	EP/USP	DMF in processususus	--
Medium-Chain Triglycerides	CP/USP/EP	DMF	--
Benzalkonium Chloride	USP/EP/JP	CEP in processuu	8001-54-5
Oleum olivae (For Iniectio)	CP/USP/EP/JP	DMF in processususus	8001-25-0
Ovum phospholipids (nam Iniectio)	CP/USP/EP	DMF	93685-90-6
PORTIO	In domo	DMF in processususus	203787-91-1

View as

Methylprednisolone Hemisuccinate

Pro Hemisuccinate Methylprednisolone, specificatio EP, USP et CP habemus. DMF and WC available.

CAS:2921-57-5

Lege plus Mitte Inquisitionem

Cyproterone Acetate

Pro Acetate Cyproterone (CPA), CP et EP specificationes habemus, CEP/TGA/EU-GMP in promptu sunt.

CAS:427-51-0

Lege plus Mitte Inquisitionem

Levonorgestrel

Levonorgestrel notiones habet de CP/EP/USP. DMF,GMP et CEP in promptu sunt.

CAS:797-63-7

Lege plus Mitte Inquisitionem

Mifepristone

Mifepristone specificationem CP et IP.DMF et GMP approbavit.

CAS:84371-65-3

Lege plus Mitte Inquisitionem

Tibolone

Tibolone cum EP specificatione obtemperat. DMF approbatur.

CAS:5630-53-5

Lege plus Mitte Inquisitionem

Estradiol Hemihydratorum

Estradiol Hemihydratorum USP et EP specificationem habet. DMF praesto.

CAS:50-28-2

Lege plus Mitte Inquisitionem

<1 2 3 4 5...7 >

Humanwell Pharmaceuticus unus ex maximis API fabricandis in Sinis. Cum plusquam XX annos experientiae, APIs, intermediis et formulis elaboramus, fabricamus et mercaturas steroidales. Forum nostrum toto orbe terrarum operit, praesentias validas habemus in America Septentrionali, Europa, America Meridionali et Africa, cum fructibus plus quam 150 terris venditis.